Paging Dr. McClellan: FDA Calls On Brookings For PDUFA Research
This article was originally published in The Pink Sheet Daily
Executive Summary
Brookings’ Engelberg Center for Health Care Reform invited to help FDA research REMS and risk-benefit standardization, patient-reported outcomes, and other issues that were mandated in PDUFA V.